NVP -bEZ235

NVP -bEZ235 

To Order Contact us: caitlyn@ucb-bioproducts.com

BEZ235 (NVP-BEZ235)
A8246-500 500 mg
EUR 374
Description: BEZ235 is an imidazoquinoline derivative inhibiting both PI3K and mTOR kinases with low nanomolar IC50s. It was well tolerated in preclinical animal studies as well as in clinical trials with manageable gastrointestinal side-effects[1, 2].

BEZ235 (NVP-BEZ235), > 99%
BC1006-025 25mg
EUR 197

BEZ235 (NVP-BEZ235), > 99%
BC1006-050 50mg
EUR 261

BEZ235 (NVP-BEZ235), > 99%
BC1006-100 100mg
EUR 313

BEZ235 (NVP-BEZ235), > 99%
BC1006-500 500mg
EUR 658

BEZ235 Tosylate
A3238-100 100 mg
EUR 151
Description: BEZ235 is an imidazoquinoline derivative inhibiting both PI3K and mTOR kinases with low nanomolar IC50s. It was well tolerated in preclinical animal studies as well as in clinical trials with manageable gastrointestinal side-effects[1, 2].

BEZ235 Tosylate
A3238-500 500 mg
EUR 374
Description: BEZ235 is an imidazoquinoline derivative inhibiting both PI3K and mTOR kinases with low nanomolar IC50s. It was well tolerated in preclinical animal studies as well as in clinical trials with manageable gastrointestinal side-effects[1, 2].

NVP-BGJ398
2855-5
EUR 185

NVP-BHG712
2464-25
EUR 756

NVP-BHG712
2464-5
EUR 229

NVP-BKM120
2619-25
EUR 414

NVP-BKM120
2619-5
EUR 142

NVP-AUY922
1591-1
EUR 387

NVP-AUY922
1591-5
EUR 1072

NVP-TAE684
1683-5
EUR 272

NVP-ADW742
B1584-10 10 mg
EUR 367
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR).

NVP-ADW742
B1584-5 5 mg
EUR 270
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR).

NVP-ADW742
B1584-50 50 mg
EUR 1389
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR).

NVP-BEP800
B2198-1
EUR 142

NVP-BEP800
B2198-5
EUR 414

NVP-231
B2225-25
EUR 349

NVP-231
B2225-5
EUR 131

NVP-CGM097
B4677-10 10 mg
EUR 667

NVP-CGM097
B4677-100 100 mg
EUR 3557

NVP-CGM097
B4677-5 5 mg
EUR 416

NVP-CGM097
B4677-5.1 10 mM (in 1mL DMSO)
EUR 627

NVP-CGM097
B4677-50 50 mg
EUR 2388

NVP 231
B1235-10 10 mg
EUR 241
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay.

NVP 231
B1235-25 25 mg
EUR 398
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay.

NVP 231
B1235-5 5 mg
EUR 154
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay.

NVP-AEW541
B1335-25
EUR 729

NVP-AEW541
B1335-5
EUR 240

NVP-TNKS656
B6046-10 10 mg
EUR 773
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-TNKS656
B6046-100 100 mg
EUR 3306
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-TNKS656
B6046-25 25 mg
EUR 1298
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-TNKS656
B6046-5 5 mg
EUR 466
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-TNKS656
B6046-5.1 10 mM (in 1mL DMSO)
EUR 502
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-TNKS656
B6046-50 50 mg
EUR 2222
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1].

NVP-AEW541
E1KS1034 2mg
EUR 718

NVP-ADW742
E1KS1088 5 mg
EUR 874

NVP-BEP800
E1KS1498 5mg
EUR 874

NVP-BHG712
E1KS2202 5mg
EUR 874

NVP-BSK805
E1KS2686 5mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 1111

NVP-BEP800
A4064-10 10 mg
EUR 270
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90.

NVP-BEP800
A4064-100 100 mg
EUR 1163
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90.

NVP-BEP800
A4064-25 25 mg
EUR 525
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90.

NVP-BEP800
A4064-5 5 mg
EUR 177
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90.

NVP-BGT226
A8488-10 10 mg
EUR 363
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM.

NVP-BGT226
A8488-5 5 mg
EUR 241
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM.

NVP-BGT226
A8488-5.1 10 mM (in 1mL DMSO)
EUR 322
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM.

NVP-BGT226
A8488-50 50 mg
EUR 920
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM.

NVP-BVU972
A8489-10 10 mg
EUR 351
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON).

NVP-BVU972
A8489-5 5 mg
EUR 270
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON).

NVP-BVU972
A8489-5.1 10 mM (in 1mL DMSO)
EUR 305
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON).

NVP-BVU972
A8489-50 50 mg
EUR 1036
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON).

NVP-BHG712
A8683-10 10 mg
EUR 235
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand.

NVP-BHG712
A8683-200 200 mg
EUR 1790
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand.

NVP-BHG712
A8683-5 5 mg
EUR 148
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand.

NVP-BHG712
A8683-5.1 10 mM (in 1mL DMSO)
EUR 212
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand.

NVP-BHG712
A8683-50 50 mg
EUR 769
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand.

NVP-BAG956
A3672-10 10 mg
EUR 312
Description: NVP-BAG956(BAG 956) is a potent, ATP-competitive and selective dual PI3K and PDK1 inhibitor in vitro and in vivo,with IC50 values to be 56, 444, 34, 117 and 240 nM for PI3K p110 alpha, beta, delta and gamma and PDK1 kinases, respectively.

NVP-BAG956
A3672-5 5 mg
EUR 221
Description: NVP-BAG956(BAG 956) is a potent, ATP-competitive and selective dual PI3K and PDK1 inhibitor in vitro and in vivo,with IC50 values to be 56, 444, 34, 117 and 240 nM for PI3K p110 alpha, beta, delta and gamma and PDK1 kinases, respectively.

NVP-BSK805
A3675-10 10 mg
EUR 316
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-BSK805
A3675-200 200 mg
EUR 2010
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-BSK805
A3675-5 5 mg
EUR 247
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-BSK805
A3675-5.1 10 mM (in 1mL DMSO)
EUR 266
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-BSK805
A3675-50 50 mg
EUR 734
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-BSK805
A3675-S Evaluation Sample
EUR 81
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase.

NVP-LCQ195
A3676-10 10 mg
EUR 466
Description: NVP-LCQ195 is a pan-inhibitor of CDKs [1].Cyclin-dependent kinases (CDKs) are a family of protein kinases and play an important role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells.

NVP-LCQ195
A3676-5 5 mg
EUR 347
Description: NVP-LCQ195 is a pan-inhibitor of CDKs [1].Cyclin-dependent kinases (CDKs) are a family of protein kinases and play an important role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells.

NVP-AEW541
A2278-100 100 mg
EUR 885
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative.

NVP-AEW541
A2278-2 2 mg
EUR 154
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative.

NVP-AEW541
A2278-25 25 mg
EUR 432
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative.

NVP-AEW541
A2278-5 5 mg
EUR 189
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative.

NVP-AEW541
A2278-5.1 10 mM (in 1mL DMSO)
EUR 189
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative.

NVP-BAW2881
HY-100394 100mg
EUR 785

NVP-2
HY-12214A 5mg
EUR 533

NVP-BHG712
HY-13258A 50mg
EUR 807

NVP-BAG956
HY-13333 5mg
EUR 291

NVP 231
HY-13945 10mM/1mL
EUR 153

NVP-TNKS656
HY-13990 5mg
EUR 366

NVP-BSK805
HY-14722 10mg
EUR 340

NVP-HSP990
HY-15190 10mM/1mL
EUR 210

NVP-LCQ195
HY-15241 5mg
EUR 402

NVP-BVU972
HY-15456 10mg
EUR 483

NVP-CGM097
HY-15954 10mg
EUR 559

NVP-ACC789
HY-19624 10mM/1mL
EUR 189

NVP-AEW541
HY-50866 2mg
EUR 173

NVP -bEZ235

Site Title, Some rights reserved.

Terms of Use - Privacy Policy

WordPress Di Blog Theme